Drug Profile
Human thrombin topical - Grifols
Alternative Names: Topical Thrombin (Human) GrifolsLatest Information Update: 24 Nov 2021
Price :
$50
*
At a glance
- Originator Grifols
- Class Antifibrinolytics; Antihaemorrhagics; Blood coagulation factors; Coagulants; Recombinant proteins; Serine endopeptidases
- Mechanism of Action Blood coagulation stimulants; Thrombin replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Surgical blood loss
Most Recent Events
- 23 Mar 2017 No recent reports of development identified - Phase-II for Surgical blood loss (Prevention) in USA (Topical)
- 01 Nov 2015 Grifols completes a phase II trial for Surgical blood loss (Prevention) in USA (NCT02014402)
- 17 Feb 2014 Phase-II clinical trials in Surgical blood loss (prevention) in USA (Topical)